Xeris Biopharma Appoints Menassie M. Taddese to Board of Directors

Bitget2026/11/02 13:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Xeris Biopharma appointed Menassie M. Taddese to its board, effective today. He will also serve on the Audit Committee.
Taddese most recently served as president of emerging markets at Viatris. His background includes more than 20 years at Pfizer.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xeris Biopharma Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261102898192) on November 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Xeris Biopharma Appoints Menassie M. Taddese to Board of Directors

You may also like

Crypto prices